Ureter and Renal Pelvis Cancer News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ureteroscopy, Lithotripsy Have Different Risk-benefit Profile for Upper Ureteral Stones Ureteroscopy, Lithotripsy Have Different Risk-benefit Profile for Upper Ureteral Stones
Ureteroscopy and shock-wave lithotripsy have different relative benefits and harms in patients with upper ureteral stones, according to a new systematic review.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - May 11, 2017 Category: Urology & Nephrology Tags: Urology News Source Type: news

Carrying Savanna through her journey with cloacal malformation
When two-year-old Savanna Bluford enters Boston Children’s Colorectal and Pelvic Malformation Center, she quickly gravitates toward the waiting room’s interactive light board. Sporting pigtails, sparkly sneakers and an angelic smile, the playful toddler’s attention quickly turns to her doctor — the Center’s Co-Director Dr. Belinda Dickie. The two light up with smiles and exchange hugs as if old friends — and that, they are. Savanna was born in South Carolina with a rare and complex birth defect affecting the gastrointestinal, urological and reproductive systems. The condition, called covered cloacal malformatio...
Source: Thrive, Children's Hospital Boston - May 3, 2017 Category: Pediatrics Authors: Maureen McCarthy Tags: Diseases & Conditions Our Patients’ Stories Belinda Dickie cloacal malformation Colorectal and Pelvic Malformation Center Leonel Rodriguez Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 12, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters. 5. GE, Hartford Healthcare ink 7-year value based care partnership GE Healthcare said today it is collaborating with Hartford HealthCare to launch a series of value-based healthcare projects over the next 7 years. The companies sa...
Source: Mass Device - April 12, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Cook Medical recalls select Bush ureteral illuminating caths
Cook Medical this week released information on a select voluntary recall of its Bush DL and Bush SL ureteral illuminating catheter sets over issues with overheating. The Bloomington, Ind.-based company said it has received an increased number of reports of the proximal black component that connects to the distal transparent component overheating and melting, which could potentially cause burns. Cook Medical clarified that it has received no reports of any overheating along the transparent component of the catheter which comes into contact with the patients’ urethra, bladder and ureter. The recall affects Bush DL cath s...
Source: Mass Device - April 12, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Recalls Urology Cook Medical Source Type: news

From Interventional Radiologist to Medtech CEO: Interview with Dr. Bob Smouse, Founder of BrightWater Medical
Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group Director for WCG. We hope you enjoy them! Dr. Bob Smouse has over 20 years of experience in interventional radiology, endovascular surgery and clinical research. In addition to acting as CEO and CMO of BrightWater Medical and teaching at the University of Illinois College of Medicine, he provides interventional medical services to local hospitals through Central Illinois Radiology Associates. Dr. Smouse is a medical consultant and scientific advisory board member for a ho...
Source: Mass Device - February 10, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Blog medsider Smouse Source Type: news

DeviceTalks Q & A: Verb Surgical CEO Scott Huennekens
Few CEOs have been given the mandate Scott Huennekens was charged with as employee No. 1 at Verb Surgical, the robotics spinout backed by Google (NSDQ:GOOG) and Johnson & Johnson (NYSE:JNJ): Go forth and change the world. “Don’t worry about capital, don’t worry about funding,” Huennekens told MassDevice.com publisher Brian Johnson recently. “Just go out and change the world.” Many CEOs might find that daunting. Then again, most CEOs don’t have a $400 million war chest and the backing of 2 of the world’s most innovative companies. And, as you’ll find out in this interview, Huennekens may not be ...
Source: Mass Device - December 21, 2016 Category: Medical Equipment Authors: MassDevice Tags: DeviceTalks Q&A Robot-Assisted Surgery Wall Street Beat Alphabet Google Inc. Johnson & Johnson Medtronic Verb Surgical Volcano Corp. Source Type: news

Convertible Stent for Ureteral Obstruction Clears FDA Convertible Stent for Ureteral Obstruction Clears FDA
The ConvertX nephroureteral stent system converts from a catheter to a stent in a short office procedure, eliminating the need for a second interventional procedure.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 5, 2016 Category: Consumer Health News Tags: Urology News Alert Source Type: news

MassDevice.com +5 | The top 5 medtech stories for December 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters. 5. FDA clears BrightWater Medical’s ConvertX nephroureteral stent Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating uret...
Source: Mass Device - December 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA clears BrightWater Medical ’ s ConvertX nephroureteral stent
Ureteral medical device company BrightWater Medical said today it won FDA 510(k) clearance for its ConvertX nephroureteral stent system designed for treating ureteral obstructions. The ConvertX System is designed as a single device intended to replace a series of devices and procedures used to treat severe obstructions of the ureter. Traditional interventions require an implanted nephrostomy catheter to externally drain urine and a second procedure to implant a nephroureteral stent to circumvent blockage. Mountain View, Calif.-based BrightWater’s system is designed to be implanted once and convert from a nephroureteral...
Source: Mass Device - December 2, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Urology BrightWater Medical Source Type: news

Dx: Prostatic Mass
Upon seeing the images on the screen, you notice a tinge of red in your resident’s cheeks as she begins her spiel about the need to perform a prostate exam as part of the work up today. She eloquently explains to the patient that the ultrasound results and his symptoms are concerning for a prostatic mass that is eroding into the base of his urinary bladder (Image 3). On the transverse view of the bladder a hyperechoic mass can be seen along the posterior wall of the bladder. In the longitudinal view, you can see the hypoechoic lumen of the mass originating from the prostate to the lower left of the bladder wall. Your res...
Source: EPMonthly.com - December 2, 2016 Category: Emergency Medicine Authors: Logan Plaster Tags: Uncategorized Source Type: news

Meta-Analysis: Alpha Blockers Associated with Passage of Ureteral Stones (FREE)
By Kelly Young Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS Alpha blockers are associated with high rates of ureteral stone passage, a meta-analysis in The BMJ finds.Researchers analyzed … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 1, 2016 Category: Primary Care Source Type: news

Sodium Fluorescein, 10% Dextrose Show Ureteral Patency Best Sodium Fluorescein, 10% Dextrose Show Ureteral Patency Best
Both solutions showed urine jets more clearly than saline or oral phenazopyridine with no increase in operative time or morbidity, data from a randomized trial show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Your NEJM Group Today: Scaling Patient Engagement Initiatives, Tamsulosin for Ureteral Stones, Ohio FM/IM Opportunities (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here ' s what we chose for you today:NEJM Catalyst: When … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 19, 2016 Category: Primary Care Source Type: news

Medical Expulsive Therapy Might Benefit Patients With Larger Ureteral Stones, Group Says Medical Expulsive Therapy Might Benefit Patients With Larger Ureteral Stones, Group Says
Medical expulsive therapy (MET) with alpha-blockers might enhance the passage of distal ureteral stones larger than 5 mm, according to a position statement from the European Association of Urology.Reuters Health Information (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - September 6, 2016 Category: Urology & Nephrology Tags: Nephrology News Source Type: news

Texas Medical Centers adds 11 medtech startups to incubator
The Texas Medical Center Innovation Institute on Wednesday announced the addition of 11 startups specifically focused on medical devices, a 1st for the incubator, as part of its TMCx program. As part of the program, for 15 weeks the startups will engage and collaborate with “top industry experts” to move their medical devices from concept to commercialization, the group said. Startup companies will also meet with stakeholders at the 56 member institutions within the Texas Medical Center. “Very few accelerators have a robust program devoted to medical device startups, so we are filling a huge gap in the li...
Source: Mass Device - August 12, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Research & Development Texas Medical Center Innovation Institute Source Type: news